LONDON/ZURICH, June 29 (Reuters) - Roche launched its next-generation gene sequencing machine on Monday, marking a bid by the Swiss drugmaker and diagnostics group to loosen U.S.-based Illumina's grip ...
Roche may have failed to buy out Illumina back in 2012, but now it’s trying to take up some of the gene sequencing specialist’s market share with its own next-gen platform. Roche’s Axelios 1 delivers ...
TEL AVIV, Israel & LEHI, Utah & HOUSTON & FREMONT, Calif.--(BUSINESS WIRE)--MyHeritage, the leading global platform for family history and DNA testing, announced today a landmark move to Whole Genome ...
When it comes to finding answers, every moment counts—especially in critical care settings like the neonatal and pediatric intensive care units (NICU and PICU). Although rapid genetic tests, whether ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results